Item — HN Reader

>which are typically fairly limited for any given generic

Nonsense. Aspirin is a generic drug. Generic drugs are widely produced because a) again, anyone can make them so b) profit margins are very thin. Thus, c) the only way to profit is through volume.

HCQ is a very common generic drug; it is given prophylactically to those traveling to malaria areas, for example. Any COVID19-driven short-term shortages are going to affect the manufacturers' bottom lines in relatively small ways. Again, I ask: What evidence is there that Trump or anyone else had a financial incentive to untowardly push HCQ?

> What evidence is there that Trump or anyone else had a financial incentive to untowardly push HCQ?

I assume you are not denying that they did push it - so, I want to ask in return: for what other reason did they (specifically Bolsonaro and Trump) push it in this way? Given that it was not backed by science.

Back then there was real hope that HCQ was indeed going to be a breakthrough treatment. Or do you also claim that Emmanuel Macron was also motivated by financial reasons when he made a well publicized visit to Didier Raoult? https://www.france24.com/en/20200409-macron-visits-marseille...